Skip to main content

Table 2 Median of the baseline characteristics across the groups

From: Effectiveness of a nurse-led management intervention on systolic blood pressure among type 2 diabetes patients in Uganda: a cluster randomized trial

Variable Median (IQR)

Intervention (n = 192)

Control (n = 196)

Age at DM Diagnosisa

48.90 (± 9.50)

50.10 (± 9.27)

DM Duration (IQR)

5 (3.00–10.00)

6 (2.00–11.00)

Systolic BP (mmHg)

144.84 (131.00–158.30)

137.50 (127.45–149.50)

Diastolic BP (mmHg)

87.00 (80.64–95.84)

84.85 (78.50–91.00)

HBA1C (%)

8.90 (6.90–11.30)

8.10 (7.00–10.40)

ASCVD Score (%)

15.09 (9.44–22.43)

13.21 (8.68–19.44)

BMI (kg/m2)

28.90 (26.22–33.25)

29.40 (25.65–33.10)

FBG (mmol/l)

8.70 (6.50–11.70)

8.60 (6.70–11.25)

TC (mmol/l)

5.25 (4.55–6.23)

5.41 (4.70–6.40)

LDL (mmol/l)

3.41 (2.61–4.14)

3.58 (2.82–4.29)

HDL (mmol/l)

1.25 (1.07–1.48)

1.27 (1.09–1.58)

TG (mmol/l)

1.89 (1.32–2.53)

1.78 (1.31–2.74)

  1. n Frequency, SD Standard deviation, DM Diabetes mellitus, BP Blood pressure, IQR Interquartile range, HbA1c Glycated hemoglobin, ASCVD Atherosclerotic cardiovascular disease, BMI Body mass index, FBG Fasting blood glucose, T.C Total cholesterol, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, TG Triglycerides
  2. aExpressed as mean and SD